title: Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer.
authors.forename: Cicely
authors.initials: C
authors.lastname: Bryce
authors.forename: Hagen
authors.initials: H
authors.lastname: Kennecke
authors.forename: Stephen
authors.initials: S
authors.lastname: Chia
authors.forename: Joseph
authors.initials: J
authors.lastname: Ragaz
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D011960:Receptors, Estrogen; D017239:Paclitaxel